tirzepatide 是 什么 减肥神药”头衔不保！研究发现替尔泊肽比司美格鲁肽效果更好 礼来替尔泊肽Tirzepatide，减肥药物对决：替尔泊肽vs司美格鲁肽-企业动态-丁香通

Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM

Prior experience with GLP-1 medications provides some guidance but does not guarantee similar experiences with multi-receptor agonists

Both act locally in the gut but via different mechanisms, so some patients respond better after the switch

As the use of GLP-1 receptor agonists continues to expand for the treatment of type 2 diabetes and obesity, questions have emerged about their potential gastrointestinal side effectsparticularly gastroesophageal reflux disease (GERD)

The active compounds (gingerols and shogaols) work on the same serotonin receptors that prescription anti-nausea medications target

For some patients, maintenance involves: A lower dose than used during active weight loss Less frequent dosing Continued appetite support without ongoing weight loss The purpose of maintenance is stability, helping appetite feel manageable while healthy habits are fully established